Decision to Acquire 95.77% Stake in P&N Pharm for about 3.74 Billion Won
- Acquisition of shares in another corporation: Decision to acquire 49,800 shares (95.77% stake) of P&N Pharm for 3,735,000,000 won in cash
- Purpose: Strengthen business capabilities and expand business areas
- Expected acquisition date: 2026-05-29
- Financial status of issuer (P&N Pharm) for 2025: Assets 5,522 million won, Liabilities 1,910 million won, Equity 3,612 million won, Revenue 4,954 million won, Net income 250 million won - declining trend in revenue and net income year-on-year
- Acquisition cost is 7.42% of equity (50,327 million won) and 4.78% of total assets (78,160 million won)
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Decision on Acquisition of Stocks and Investment Securities of Other Corporations (Voluntary Disclosure)
- Company: Tego Science (191420)
- Submission: Tego Science, Inc.
- Receipt: 05-19-2026
- Under KRX KOSDAQ Market Division